Biofortuna secures £1.1 million
Early stage investment firms EV and Catapult Venture Managers have backed Liverpool-based molecular diagnostics company Biofortuna.
News
Early stage investment firms EV and Catapult Venture Managers have backed Liverpool-based molecular diagnostics company Biofortuna.
News
Partner content
Accounting and Finance Software
Accounting and Finance Software